1. Home
  2. XOMAP vs QIWI Comparison

XOMAP vs QIWI Comparison

Compare XOMAP & QIWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAP
  • QIWI
  • Stock Information
  • Founded
  • XOMAP N/A
  • QIWI N/A
  • Country
  • XOMAP United States
  • QIWI
  • Employees
  • XOMAP 13
  • QIWI 3019
  • Industry
  • XOMAP Biotechnology: Pharmaceutical Preparations
  • QIWI
  • Sector
  • XOMAP Health Care
  • QIWI
  • Exchange
  • XOMAP Nasdaq
  • QIWI NYSE
  • Market Cap
  • XOMAP N/A
  • QIWI N/A
  • IPO Year
  • XOMAP N/A
  • QIWI N/A
  • Fundamental
  • Price
  • XOMAP $25.90
  • QIWI $5.67
  • Analyst Decision
  • XOMAP
  • QIWI
  • Analyst Count
  • XOMAP 0
  • QIWI 0
  • Target Price
  • XOMAP N/A
  • QIWI N/A
  • AVG Volume (30 Days)
  • XOMAP N/A
  • QIWI N/A
  • Earning Date
  • XOMAP N/A
  • QIWI N/A
  • Dividend Yield
  • XOMAP N/A
  • QIWI N/A
  • EPS Growth
  • XOMAP N/A
  • QIWI N/A
  • EPS
  • XOMAP N/A
  • QIWI N/A
  • Revenue
  • XOMAP N/A
  • QIWI N/A
  • Revenue This Year
  • XOMAP N/A
  • QIWI N/A
  • Revenue Next Year
  • XOMAP N/A
  • QIWI N/A
  • P/E Ratio
  • XOMAP N/A
  • QIWI N/A
  • Revenue Growth
  • XOMAP N/A
  • QIWI N/A
  • 52 Week Low
  • XOMAP N/A
  • QIWI N/A
  • 52 Week High
  • XOMAP N/A
  • QIWI N/A
  • Technical
  • Relative Strength Index (RSI)
  • XOMAP 57.20
  • QIWI N/A
  • Support Level
  • XOMAP $25.31
  • QIWI N/A
  • Resistance Level
  • XOMAP $25.80
  • QIWI N/A
  • Average True Range (ATR)
  • XOMAP 0.30
  • QIWI 0.00
  • MACD
  • XOMAP -0.02
  • QIWI 0.00
  • Stochastic Oscillator
  • XOMAP 57.08
  • QIWI 0.00

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About QIWI QIWI PLC SPON ADR REPR ORD 1 CL'B'EUR0.00

QIWI PLC is engaged in operating electronic online payment systems in Russia, Kazakhstan, Moldova, Belarus, Romania, United Arab Emirates (UAE), and other countries and provides consumer and small and medium enterprises (SME) financial services. The company's segments include Payment Services, Digital Marketing, and Corporate and Others. It generates maximum revenue from the Payment Services segment. Geographically, the majority is from CIS countries.

Share on Social Networks: